We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+9.23%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$540M
AUM Growth
-$17.9M
(-3.2%)
Cap. Flow
-$41M
Cap. Flow
% of AUM
-7.6%
Top 10 Holdings %
Top 10 Hldgs %
26.96%
Holding
716
New
62
Increased
152
Reduced
248
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Malaysia ETF
EWM
|
+$10.3M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$9.74M |
| 3 |
IBM
IBM
|
+$8.96M |
| 4 |
iShares MSCI China ETF
MCHI
|
+$8.57M |
| 5 |
Linde
LIN
|
+$7.04M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$21.8M |
| 2 |
Stellantis
STLA
|
+$20.9M |
| 3 |
iShares MSCI Philippines ETF
EPHE
|
+$11.4M |
| 4 |
Ferrari
RACE
|
+$10.4M |
| 5 |
Deutsche Bank
DB
|
+$9.96M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.08% |
| 2 | Consumer Discretionary | 12.84% |
| 3 | Technology | 8.88% |
| 4 | Materials | 7.83% |
| 5 | Industrials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Vertex Pharmaceuticals
VRTX
$122B
| $11.7K | ﹤0.01% |
50
-1,066
| -96% | -$216K |
|
402
Hasbro
HAS
$12.7B
| $10.5K | ﹤0.01% |
102
| – | – |
|
|
RTN
403
DELISTED
Raytheon Company
RTN
| $10.3K | ﹤0.01% |
45
-1,059
| -96% | -$224K |
|
404
Cencora
COR
$61B
| $10.2K | ﹤0.01% |
112
-45,757
| -100% | -$3.92M |
|
405
ICICI Bank
IBN
$107B
| $10.1K | ﹤0.01% |
674
-1,722
| -72% | -$23.4K |
|
|
HEXO
406
DELISTED
HEXO Corp. Common Shares
HEXO
| $9.27K | ﹤0.01% |
89
-679
| -88% | -$89.4K |
|
407
Trinity Industries
TRN
$2.91B
| $8.94K | ﹤0.01% |
432
| – | – |
|
|
GSV
408
DELISTED
Gold Standard Ventures Corp.
GSV
| $8.88K | ﹤0.01% |
11,893
| – | – |
|
409
Marriott Vacations Worldwide
VAC
$3.35B
| $7.14K | ﹤0.01% |
56
| – | – |
|
410
Hershey
HSY
$36.6B
| $6.98K | ﹤0.01% |
47
-74
| -61% | -$11K |
|
411
Conagra Brands
CAG
$7.32B
| $6.96K | ﹤0.01% |
218
-120
| -36% | -$3.48K |
|
412
Arcosa
ACA
$7.13B
| $6.7K | ﹤0.01% |
144
| – | – |
|
413
Goldman Sachs
GS
$305B
| $6.62K | ﹤0.01% |
27
-208
| -89% | -$45.1K |
|
414
Ovintiv
OVV
$16.8B
| $6.24K | ﹤0.01% |
293
| – | – |
|
415
Cummins
CMI
$90.1B
| $6.21K | ﹤0.01% |
36
| – | – |
|
416
Cognizant
CTSH
$22.6B
| $6.18K | ﹤0.01% |
100
-12,384
| -99% | -$765K |
|
417
TG Therapeutics
TGTX
$8.57B
| $6.13K | ﹤0.01% |
435
| – | – |
|
418
Align Technology
ALGN
$12.1B
| $6.03K | ﹤0.01% |
22
| – | – |
|
419
SS&C Technologies
SSNC
$18.3B
| $5.79K | ﹤0.01% |
93
-159
| -63% | -$8.92K |
|
420
LCI Industries
LCII
$2.52B
| $5.62K | ﹤0.01% |
52
-1,027
| -95% | -$104K |
|
|
STMP
421
DELISTED
Stamps.com, Inc.
STMP
| $5.6K | ﹤0.01% |
65
-983
| -94% | -$81.9K |
|
422
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.38B
| $5.4K | ﹤0.01% |
123
| – | – |
|
423
Thor Industries
THO
$4.03B
| $5.33K | ﹤0.01% |
66
-1,243
| -95% | -$80.2K |
|
424
Twilio
TWLO
$29.5B
| $5.27K | ﹤0.01% |
44
-761
| -95% | -$77.7K |
|
425
EastGroup Properties
EGP
$11.4B
| $5.22K | ﹤0.01% |
39
+14
| +56% | +$1.84K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q4 2019 Portfolio in Review
As of Q4 2019, Exane Derivatives held 716 positions worth $540M, down 3.2% from $558M the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Exane Derivatives withdrew a net $41M in Q4 2019, closing 35 positions and reducing 248 holdings. Its most notable exit was iShares MSCI Indonesia ETF, an estimated $6.83M position sold in full.
By sector, the portfolio is most concentrated in Financials at 13% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Technology.
Against the trend, Exane Derivatives opened a new position in IBM worth $9M.
- Exane Derivatives's largest Q4 2019 buy was IBM: 68,905 shares worth $9M.
- Exane Derivatives added most to iShares MSCI Malaysia ETF in Q4 2019, an estimated $10.3M increase.
- Exane Derivatives's biggest Q4 2019 reduction was UBS Group, cutting an estimated $21.8M.
- Exane Derivatives fully exited iShares MSCI Indonesia ETF in Q4 2019, selling an estimated $6.83M.
- Exane Derivatives's ten largest holdings make up 27% of its $540M portfolio in Q4 2019.
- Exane Derivatives opened 62 new positions and closed 35 in Q4 2019.
- Exane Derivatives's portfolio value fell 3.2% quarter-over-quarter to $540M.
Based on Exane Derivatives's 13F filing for Q4 2019, filed 22 Jan 2020.